Modified guanines representing O6-alkylation by the cyclophosphamide metabolites acrolein and chloroacetaldehyde:: Synthesis, stability, and ab initio studies

被引:12
作者
Balu, N
Gamcsik, MP
Colvin, ME
Colvin, OM
Dolan, ME
Ludeman, SM [1 ]
机构
[1] Duke Univ, Med Ctr, Dept Med, Duke Comprehens Canc Ctr, Durham, NC 27710 USA
[2] Lawrence Livermore Natl Lab, Biol & Biotechnol Res Program, Livermore, CA 94550 USA
[3] Univ Chicago, Canc Res Ctr, Chicago, IL 60637 USA
[4] Univ Chicago, Dept Med, Chicago, IL 60637 USA
关键词
D O I
10.1021/tx0101503
中图分类号
R914 [药物化学];
学科分类号
100701 [药物化学];
摘要
Alkylation of DNA by acrolein and/or chloroacetaldehyde may result in the mutations that lead to the therapy-induced leukemia associated with cyclophosphamide (and ifosfamide) treatment. O-6-(n-Propanalyl)guanine (O-6-PAG) and O-6-(ethanalyl)guanine (O-6-EAG) were synthesized for use as authentic standards in investigations of DNA alkylation by acrolein and chloroacetaldehyde, respectively. Preparation of the O-methyl oximes of these aldehydes aided in confirming the structural assignments of O-6-PAG and 06-EAG. HPLC was used to study the stability of O-6-PAG under a variety of conditions. The decomposition of O-6-PAG was attributed to an alpha,beta-elimination reaction resulting in the formation of guanine and acrolein. In 0.1 M phosphate-DMSO (9:1), O-6-PAG (1-10 mM) had a half-life of approximately 1 h (pH 7.4, 37 degreesC). In 0.05 M Tris-DMSO (9:1), the apparent half-life of O-6-PAG (1-10 mM) was approximately 16 h (pH 7.4, 37 degreesC). The increased lifetime under the latter conditions was attributed to a reversible reaction between Tris and the aldehydic functionality of O-6-PAG to give a more stable oxazolidine. Under conditions similar to those that would be used for hydrolysis of DNA [0.1 M HCl-DMSO (98:2), pH 1.3, 70 degreesC, 30 min], there was an estimated 10-35% loss of O-6-PAG. Under the same conditions, 06-EAG had apparent half-lives of 6.6 h (phosphate-DMSO) and 2.5 days (Tris-DMSO) and the estimated loss at pH 1.3 over 30 min (70 degreesC) was 15-20%. Ab initio quantum chemical calculations were used to understand the energy factors that underlie the occurrence of O- versus N-alkylations as well as possible, subsequent intramolecular cyclizations. Simulations of the free energies of reactions between acrolein and guanine indicated that N-alkylation was favored over O-6-alkylation and that cyclizations to tautomers were most favorable if they involved the N-1 or NH2 positions.
引用
收藏
页码:380 / 387
页数:8
相关论文
共 48 条
[1]
Theoretical studies on the continuum solvation of some N,N′-dimethyl- and N-methyl,N′-acetyl-guanidine and guanidinium conformers [J].
Alagona, G ;
Ghio, C ;
Nagy, PI ;
Durant, GJ .
JOURNAL OF PHYSICAL CHEMISTRY A, 1999, 103 (12) :1857-1867
[2]
Quantum calculation of molecular energies and energy gradients in solution by a conductor solvent model [J].
Barone, V ;
Cossi, M .
JOURNAL OF PHYSICAL CHEMISTRY A, 1998, 102 (11) :1995-2001
[3]
DENSITY-FUNCTIONAL THERMOCHEMISTRY .3. THE ROLE OF EXACT EXCHANGE [J].
BECKE, AD .
JOURNAL OF CHEMICAL PHYSICS, 1993, 98 (07) :5648-5652
[4]
ATOMIC CHARGES DERIVED FROM SEMIEMPIRICAL METHODS [J].
BESLER, BH ;
MERZ, KM ;
KOLLMAN, PA .
JOURNAL OF COMPUTATIONAL CHEMISTRY, 1990, 11 (04) :431-439
[5]
Structures of acrolein-guanine adducts: A semi-empirical self-consistent field and nuclear magnetic resonance spectral study [J].
Boerth, DW ;
Eder, E ;
Hussain, S ;
Hoffman, C .
CHEMICAL RESEARCH IN TOXICOLOGY, 1998, 11 (04) :284-294
[6]
THE MECHANISM OF ACTIVATION OF 4-HYDROXYCYCLOPHOSPHAMIDE [J].
BORCH, RF ;
MILLARD, JA .
JOURNAL OF MEDICINAL CHEMISTRY, 1987, 30 (02) :427-431
[7]
BASE-CATALYZED-HYDROLYSIS OF 4-HYDROPEROXYCYCLOPHOSPHAMIDE - EVIDENCE FOR IMINOCYCLOPHOSPHAMIDE AS AN INTERMEDIATE [J].
BORCH, RF ;
GETMAN, KM .
JOURNAL OF MEDICINAL CHEMISTRY, 1984, 27 (04) :485-490
[8]
Cai YN, 1999, CANCER RES, V59, P3059
[9]
Cai YN, 2000, CANCER RES, V60, P5464
[10]
SUBSTITUTED O-6-BENZYLGUANINE DERIVATIVES AND THEIR INACTIVATION OF HUMAN O-6-ALKYLGUANINE-DNA ALKYLTRANSFERASE [J].
CHAE, MY ;
MCDOUGALL, MG ;
DOLAN, ME ;
SWENN, K ;
PEGG, AE ;
MOSCHEL, RC .
JOURNAL OF MEDICINAL CHEMISTRY, 1994, 37 (03) :342-347